Jesduvroq (daprodustat) — United Healthcare
anemia due to chronic kidney disease in adults receiving dialysis
Initial criteria
- Diagnosis of anemia due to chronic kidney disease (CKD)
- Patient has been receiving dialysis for at least four months
Reauthorization criteria
- Documentation of positive clinical response to Jesduvroq therapy
Approval duration
12 months